Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $670.6400 (1.22%) ($670.6400 - $670.6400) on Tue. Dec. 14, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.84% (three month average) | RSI | 58 | Latest Price | $670.6400(1.22%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1.1% a day on average for past five trading days. | Weekly Trend | REGN advances 1.7% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(53%) DIA(39%) XLV(39%) IWD(38%) SPY(37%) | Factors Impacting REGN price | REGN will decline at least -0.92% in a week (0% probabilities). VIXM(-19%) TBT(-10%) UUP(-8%) VXX(-4%) IGOV(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.92% (StdDev 1.84%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $664.72(0.89%) | 10 Day Moving Average | $648.8(3.37%) | 20 Day Moving Average | $647.61(3.56%) | To recent high | 0% | To recent low | 23.6% | Market Cap | $71.107b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |